Cancer prognosis: Considering tumor and its microenvironment as a whole

Dan Qi¹, Erxi Wu²

Affiliations

¹ Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 78508, USA; Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76502, USA.
² Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 78508, USA; Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76502, USA; Department of Surgery, Texas A & M University College of Medicine, Temple, TX 76504, USA; Department of Pharmaceutical Sciences, Texas A & M University College of Pharmacy, College Station, TX 77843, USA; LIVESTRONG Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: erxi.wu@bswhealth.org.

Dan Qi et al. EBioMedicine. 2019 May.

. 2019 May:43:28-29.

doi: 10.1016/j.ebiom.2019.04.031. Epub 2019 Apr 19.

Dan Qi¹, Erxi Wu²

¹ Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 78508, USA; Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76502, USA.
² Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 78508, USA; Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76502, USA; Department of Surgery, Texas A & M University College of Medicine, Temple, TX 76504, USA; Department of Pharmaceutical Sciences, Texas A & M University College of Pharmacy, College Station, TX 77843, USA; LIVESTRONG Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: erxi.wu@bswhealth.org.

No abstract available

Keywords: CRC; Prognosis; TME; TNM.

References

1. Balkwill F.R., Capasso M., Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591–5596. - PubMed
1. Joyce J.A., Fearon D.T. T cell exclusion, immune privilege, and the tumor microenvironment. Science (New York, NY) 2015;348(6230):74–80. - PubMed
1. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–322. - PubMed
1. Li X., Ma Q., Xu Q., Duan W., Lei J., Wu E. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. Curr Pharm Des. 2012;18(17):2404–2415. - PMC - PubMed
1. Bridelance J., Drebert Z., De Wever O., Bracke M., Beck I.M. When neighbors talk: colon cancer cell invasion and tumor microenvironment myofibroblasts. Curr Drug Targets. 2017;18(8):964–982. - PubMed